Can eltrombopag be taken for a long time? Is it risky?

Eltrombopag/Eltrombopag (Eltrombopag) is widely used in the long-term management of chronic immune thrombocytopenia (ITP) , aplastic anemia (AA) and other diseases due to its convenient oral administration and accurate efficacy. However, patients and family members often have questions: Can this drug be taken for a long time? Will long-term use bring greater risks?

From the perspective of its mechanism of action, eltrombopag is an agonist that selectively stimulates the thrombopoietin receptor and promotes the maturation of bone marrow megakaryocytes by activating signaling pathways, thereby increasing platelet production. Unlike traditional immunosuppressants or glucocorticoids, it does not directly suppress the immune system, thus reducing the risk of serious infections caused by long-term medication to a certain extent. This is one of the important reasons why it is gradually accepted in the long-term management of chronic diseases.

Multiple overseas real-world studies have shown that some patients can maintain stable platelet levels and controllable adverse reactions when taking eltrombopag for a long time. However, long-term use is not completely risk-free, and we mainly need to pay attention to the following aspects: First, long-term stimulation of the hematopoietic system may increase the risk of myelofibrosis in rare cases, so it is recommended to conduct regular bone marrow and blood routine examinations; second, if the platelet level is too high for a long time, it may increase the risk of myelofibrosis. The risk of thrombotic events, especially in patients with hypertension, hyperlipidemia or a history of thrombosis, requires more careful monitoring; third, eltrombopag is metabolized in the liver, so patients taking the drug for a long time need to regularly monitor liver function to promptly detect potential elevated liver enzymes or abnormal liver function.

In addition, we need to be alert to the possibility of drug resistance or weakened response during long-term medication. Some patients will experience a decline in efficacy after taking medication for several months or years, and need to adjust the treatment plan or combine it with other treatments. Doctors usually regularly evaluate whether to continue, reduce or suspend eltrombopag treatment based on changes in the condition to achieve a balance between efficacy and safety.

Reference materials:https://go.drugbank.com/drugs/DB06210